Extremadura Implements New More Powerful 20-Valent Conjugate Vaccine (Apexxnar) in Common Vaccination Schedule
The 20-valent conjugate vaccine (Apexxnar, from the Pfizer laboratory) replaces the 13-valent injectable (VNC-13) in the Common Vaccination Schedule of Extremadura from January 1, 2024. This “more powerful” vaccine protects against serious infections caused by the pneumococcus bacteria (which causes serious pathologies such as pneumonia and meningitis) and its potential complications. According to the Spanish … Read more